Genvoya tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26FHP7B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,968
Award facts
- Contract value 100% obligated
- $14,967.77 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $14,967.77 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Genvoya tablets (30-tablet units) with an ultimate completion date of October 22, 2025. This non-set-aside contract was competitively awarded on October 21, 2025, with performance occurring at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive pharmaceutical prime vendor agreement running through December 2026 that enables the company to supply medications and medical supplies globally to military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this flexible contract vehicle. Genvoya is an antiretroviral medication used in HIV treatment, reflecting the company's extensive portfolio of specialty and brand-name pharmaceuticals delivered under the DLA Medical Supply Chain. The award demonstrates AmerisourceBergen's continued capability to fulfill federal procurement requirements through open competition, consistent with its pattern of competitively awarded delivery orders ranging from minimal to substantial values under the pharmaceutical prime vendor program.
Quick answers
Who was awarded contract SPE2DR26FHP7B?
SPE2DR26FHP7B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DR26FHP7B worth?
The government has obligated $14,968 on SPE2DR26FHP7B.
Is contract SPE2DR26FHP7B an order under another contract?
Yes. SPE2DR26FHP7B is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHP7B competed?
The extent of competition for SPE2DR26FHP7B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award